A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy

NCT00506207 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

23

Enrollment

OTHER_GOV

Sponsor class

Conditions

Colorectal Neoplasm
Gastric Neoplasm
Secondary

Interventions

DRUG: S-1, Irinotecan, Oxaliplatin

Sponsor

National Cancer Center, Korea